MV TELEGRAPH DAILY NEWS
Fruit bats seen hanging on tree branches in daylight. Bats are believed to be one of the carriers of Nipah virus, a zoonotic disease that spreads from animals to humans. Eyepix Group | Future Publishing | Getty Images Health authorities in the southern Indian state of Kerala are on high alert following the latest flare-up of the …
Continue reading “What you want to know as India points an alert”
Dr. Scott Gottlieb is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. He is a CNBC contributor and is a member of the boards of Pfizer and several other startups in health and tech. He is also a partner at the venture capital firm New Enterprise Associates. Shani …
Continue reading “How effectively can AI chatbots mimic docs in a remedy setting?”
The job market may have cooled a bit, but there are still far more job openings nationwide than there are people available to fill them. That means qualified workers are still a precious commodity. So, companies seeking to attract great employees like to set up shop in states that offer a great quality of life. …
Continue reading “These are the 10 worst U.S. states for high quality of life”
Aykut Karahan | Istock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Several drugmakers are hurrying to capitalize on one of the next major innovations coming to the booming weight loss drug market: effective, convenient and potentially affordable obesity pills. Most of the …
Continue reading “Drugmakers are racing to develop weight reduction tablets”
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | Reuters Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition. Semaglutide, which is present in weight loss drugs including Novo Nordisk’s Ozempic …
Continue reading “Novo Nordisk weight reduction medicine linked to uncommon eye situation: research”
A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Scott Olson | Getty Images The Food and Drug Administration on Tuesday approved Eli Lilly‘s Alzheimer’s drug donanemab, expanding the limited treatment options for the mind-wasting disease in the U.S. The …
Continue reading “FDA approves Eli Lilly Alzheimer’s drug donanemab”
Spectators watch a race on the River Thames at the Henley Royal Regatta in Henley-on-Thames, west of London, on June 30, 2023. Henry Nicholls | Afp | Getty Images LONDON — Harmful E.coli bacteria has been discovered at “alarmingly high” levels in the U.K.’s River Thames just days before elite rowers are due to compete …
Continue reading “Micro organism in Thames forward of rowing Henley Regatta”
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a decision as early as the end of the year. If cleared by the Food and Drug Administration, the company plans to launch Zepbound for so-called obstructive …
Continue reading “Eli Lilly expects FDA name on Zepbound for sleep apnea in close to time period”
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. The injectable weight loss medication Wegovy at New City Halstead Pharmacy in Chicago on April 24, 2024. Scott Olson | Getty Images Good morning! More U.S. employers are covering a buzzy class of medications called GLP-1s for weight …
Continue reading “Extra U.S. employers masking GLP-1s for weight reduction”
Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help physicians provide more accurate treatment for their patients, rose by as much as 15% in its Nasdaq Stock Market debut on Friday, after going public under the ticker symbol “TEM.” Tempus AI priced 11.1 million shares at $37 apiece on …
Continue reading “Google-backed Tempus AI closes first buying and selling day up 9% in Nasdaq debut”
